Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey.

Vittorio PengoTeresa Del RossMarta TonelloLaura AndreoliAngela TincaniPaolo GreseleElena SilvestriPaolo SimioniElena CampelloAriela HoxhaAnna FalangaAngelo GhirarduzziGentian Denasnull null

Published in: Rheumatology (Oxford, England) (2022)

Patients with triple-positive thrombotic APS did not suffer from severe COVID-19 outcomes. Importantly, COVID-19 vaccination was well tolerated. These data may reassure patients and physicians and contribute to reducing hesitancy in unvaccinated patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
primary care
early onset
electronic health record
patient reported
insulin resistance
weight loss
artificial intelligence
data analysis